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Aims.Thegoal ofcell transcriptionfortreatmentofdiabetes istogenerate surrogate β-cells fromanappropriate cell line.However,
the induced replacement cells have showed less physiological function in producing insulin compared with normal β-cells.
Methods. Here, we report a procedure for induction of insulin-producing cells (IPCs) from bone marrow murine mesenchymal
stemcells(BM-mMSCs).TheseBM-mMSCshavethepotentialtodiﬀerentiateintoinsulin-producingcellswhenacombinationof
PDX-1 (pancreatic and duodenal homeobox-1), NeuroD1 (neurogenic diﬀerentiation-1), and MafA (V-maf musculoaponeurotic
ﬁbrosarcoma oncogene homolog A) genes are transfected into them and expressed in these cells. Results. Insulin biosynthesis and
secretion were induced in mMSCs into which these three genes have been transfected and expressed. The amount of induced
insulin in the mMSCs which have been transfected with the three genes together is signiﬁcantly higher than in those mMSCs that
were only transfected with one or two of these three genes. Transplantation of the transfected cells into mice with streptozotocin-
induced diabetes results in insulin expression and the reversal of the glucose challenge. Conclusions. These ﬁndings suggest major
implications for cell replacement strategies in generation of surrogate β-cells for the treatment of diabetes.
1.Introduction
Type1diabetesischaracterisedbyabsoluteinsulindeﬁciency
caused by T-cell-mediated destruction of pancreatic β-cells.
β-Cell replacement is a promising approach for treatment of
type 1 diabetes. Islet cell replacement has been considered
as the potential cure for diabetes over the past thirty years.
However, this treatment is limited by a shortage of pancreas
donors and immune rejection against islets. Recently, the
methods of obtaining insulin-producing surrogate β-Cells
from non-β-cells through induction or genetic engineering
have been investigated, which supports a new sight in Type 1
diabetes treatment [1–4].
Transcription factors control biological processes such
as diﬀerentiation, proliferation, and apoptosis. They bind
to the speciﬁc sequence within the region of the promoter
or enhancer and activate specialized genes’ expression. It
has been reported that a number of transcription factors
were involved in pancreas β-cells’ development and function
maintaining [5]. It has been reported that PDX-1, NeuroD1
and MafA directly bind to the insulin gene promoter and
promote transcription of insulin mRNA and maintenance of
β-cell function during pancreatic β-cell diﬀerentiation. Fur-
ther studies have also shown that the transcription of these
three genes and their resultant three protein products are
crucial for glucose regulation of insulin production [6]. But
whether synergistic eﬀect may induce higher insulin expres-
sion and promote non-β-cells further diﬀerentiated into β-
cells in vivo or in vitro is still needed to be further studied.
Recently, MSCs were chosen as target cells for transplan-
tation, because of their ability to diﬀerentiate into multiple
cell types [7, 8], their ability to elude detection by the host’s2 Experimental Diabetes Research
immune system [9], and the relative ease of expanding these
cells in cell culture [9]. In our study, a combination of these
three transcription factors, which all play a crucial role in
glucose induction of insulin gene transcription and pan-
creatic β-cell function, were delivered into mMSCs on
adenoviral vectors. After infection, the cells were cultured
in deﬁned conditions with epidermal growth factor (EGF)
to promote transdiﬀerentiation and were found to have an
active endogenous insulin gene.
There are some ﬁndings demonstrating the feasibility of
inducing a functional alteration in cultured MSCs by expres-
sion of a single master pancreatic regulator gene [10, 11]. In
the previous study, we have successfully generated IPCs from
bone marrow MSCs by introduction of a human insulin
gene [12]. After the transfected cells were injected into the
liver of mice with diabetes, we found that the hyperglycemia
in mice with diabetes could be reversed eﬀectively [13].
However, the cells for transplantation showed weak glucose
responsiveness and immaturity. There remains a sizable
gap between induced cells and normal islet β-cells. The
recent work on induced pluripotent stem cells (iPS cells) and
induced neuron formation suggests that a speciﬁc combi-
nation of multiple transcription factors instead of a single
one might be suﬃc i e n tt od i r e c t l yr e p r o g r a ma d u l tc e l l s
[14, 15]. A number of transcription factors play important
roles in the processes of β-cell diﬀerentiation and to some
extent other genes are responsible for maintaining β-cell
function. Here, in the present study, the combination of
PDX-1, NeuroD1, and MafA markedly induces insulin bio-
synthesis and secretion in mMSCs and thereby this is a novel
approach to induce insulin-producing surrogate β-cells
eﬃciently for transplantation.
2.MaterialsandMethods
2.1. Construction of Recombinant Adenovirus Vectors Harbor-
ing Target Gene. The genes of mouse transcription factors
PDX-1, NeuroD1, and MafA (gene ID: 18609, 18012,
378435) were obtained by total gene synthesis and gene seq-
uencing to validate that the synthesis was correct. The
encoding sequences of PDX-1, NeuroD1, and MafA were
ampliﬁed and ligated with an internal ribosome entry site
sequence-green ﬂuorescent protein (IRES-GFP) by PCR,
then cloned into a shuttle vector pDONR221 by BP clonase
II enzyme mix (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s protocol. The corrcet recombinant plas-
mids were then cloned into the pAD/CMV/V5-DEST aden-
oviralvectors(Invitrogen,Carlsbad, CA,USA)by LRclonase
II enzyme mix (Invitrogen, Carlsbad, CA, USA) accord-
ing to the manufacturer’s protocol. Electrophoretic analysis
and DNA sequencing were performed to identify the recom-
binant vectors.
2.2. Adenovirus Production. After the cells were counted, the
packaging cell line 293A in logarithmic growth phase was
incubated in a 6-well culture plate at 37◦C, 5% CO2 the day
before transfection. The sequences of the recombinant ade-
novirus vectors pAd-Mouse PDX-1-IRES-GFP, pAd-Mouse
NeuroD1-IRES-GFP and pAd-Mouse MafA-IRES-GFP were
conﬁrmed by gene sequencing and linearized with Pac I
and then transfected into the adenovirus packaging cell line
293A using Lipofectamine2000 (Invitrogen, Carlsbad, CA,
USA). 48 hours after transfection, cells were detached and
transferred to a petri dish. Fresh nutrient medium was added
every two or three days. The supernants were collected from
293A cells when most of the cells showed signiﬁcant cyto-
pathic eﬀect (CPE). Primary adenoviruses were harvested
after 3 times of freeze-thawing of the supernants. The pri-
mary adenoviruses were used to infect 293A cells in 10cm
petri dishes to make adenoviruses concentrated. Finally the
concentrated adenoviruses were stored at −80◦C. The con-
trol adenovirus expressing green ﬂuorescent protein (Ad-
GFP) was prepared as the above-mentioned method. The
titer of the adenovirus was determined by an immune meth-
od, as follows: the HEK-293 cells that had been infected with
adenovirus in diﬀerent concentrations were reacted with
rabbit antiadenovirus polyclonal antibody (1:1000) for 1
hour and were then incubated for additional 1 hour with
horseradish peroxidase labeled anti-rabbit antibody. After
3,3 -diaminobenzidine (DAB) staining, the titer of the ade-
novirus was calculated in terms of the number of brown
particles formed in diﬀerent dilutions.
2.3. Cell Culture. Bone marrow mMSCs from mice were
enriched and expanded in vitro by using the whole bone
marrow adherence method according to the previous pro-
tocol published from our laboratory [13], with slight modi-
ﬁcations [16]. Brieﬂy, two-month-old male C57BL/6J mice
were sacriﬁced and soaked in 75% ethanol for 3 minutes.
The femurs and tibiae were dissected away from attached
muscle and connective tissues, after which the bones were
placed in phosphate buﬀered saline (PBS) on ice. Either
of the ends of each tibia and femur was clipped, and then
the bone marrow was extruded by inserting a 21-gauge
needle into the shaft of the bone and ﬂushing with rinse
solution. Rinse solution consisted of PBS (PH 7.2), 2%
fetal bovine serum (FBS; GIBCO BRL, Gaithersburg, MD,
USA) and 1mM ethylene diamine tetraacetic acid (EDTA).
Bone marrow cells were collected by centrifugalization and
resuspended in Dulbecco’s-modiﬁed eagle’s medium/Ham’s
Nutrient Mixture F-12 (DMEM/F12; HyClone, Logan, UT,
USA) supplemented with 10% FBS, 100units/mL penicillin,
100mg/mL streptomycin, 2mM L-glutamine (Sigma Chem-
ical Company, St. Louis, MO, USA) and 10ng/mL human
basic ﬁbroblast growth factor (bFGF; ProSpec-Tany Tech-
noGene, Rehovot, Israel) to promote cell proliferation.
Cells were plated in 25cm2 culturing ﬂask (Corning Enter-
prises, Corning, NY, USA) and incubated at 37◦Cw i t h5 %
humidiﬁed CO2. The nonadherent cells were removed after
72h, and adherent cells were thoroughly washed twice with
PBS. As the cells grew to 80% conﬂuence and were treat-
ed with 0.25% trypsin-0.02% EDTA (Sigma Chemical Com-
pany, St. Louis, MO, USA) for 5 minutes at 37◦C in the ratio
1:2 at each passage. Flow cytometry was performed for
immunophenotype analysis of mMSCs. mMSCs at passage 3
were trypsinized and washed three times with PBS, then the
cells were incubated with the following labeled antibodies:Experimental Diabetes Research 3
CD14, CD29, CD34, CD44, CD45, and CD105. Labeled
cells were analyzed on a FACSort Calibur (BD Biosciences,
Franklin Lakes, NJ, USA). To conﬁrm the multipotency
character of mMSCs, mMSCs at passage 3 were incubated in
osteogenicoradipogenicdiﬀerentiationmediumfor21days,
followedbystainingwithalkalinephosphataseoroilred,res-
pectively, as described previously [17].
2.4. MOI Determination and Cell Infection. Cells were col-
lected from a highly proliferative mMSC culture at passage
3 and plated into 96 well culture plates at the same density.
On the next day cells were infected with freshly harvested
Ad-GFP at diﬀerent multiplicity of infection (MOI) from
5 to 5000 in medium containing 2% FBS and incubated
for 24h. Infection eﬃciency was determined by ﬂuorescence
microscope after a further three days, and toxicity was deter-
mined by Cell Counting Kit-8 (CCK-8; Dojindo Molecular
Technologies, Inc., Kumamoto, Japan). 10uL of CCK-8 solu-
tion was added into every well according to the instructions
on the manufacturers’ kit, followed by incubation at 37◦C
with 5% humidiﬁed CO2 for 2 hours. The absorbance of
the infected cells was measured by a microplate reader. The
optimal MOI were identiﬁed from infection eﬃciency and
toxicity. Ad-Mouse PDX-1-IRES-GFP, Ad-Mouse NeuroD1-
IRES-GFP and Ad-Mouse MafA-IRES-GFP were prepared,
and then mMSCs were infected with viruses containing the
three factors at an optimal MOI. Each of the adenovirus
has the same contribution to the optimal MOI, single gene
delivery and double infection were also performed. The fol-
lowing day the cells were switched to diﬀerentiation medium
supplemented with EGF. The infection was repeated in the
following days. The cells were infected with Ad-GFP as a
control.
2.5. Reverse Transcription Polymerase Chain Reaction. Total
cellular RNA was isolated using the MicroElute Total RNA
Kit (OMEGA BIO-TEK, GA, USA) according to the manu-
facturer’s instructions. After quantiﬁcation by spectrophoto-
metry, 2μg of RNA was used for cDNA synthesis with
a RevertAid TM First Strand cDNA Synthesis Kit (Fer-
mentas DNA International, Burlington, Canada). Polymeri-
zation reactions were performed using a 20μLr e a c t i o n
volume containing 1μL of cDNA, with the oligonucleo-
tide primers being as follows: PDX-1 (330bp), 5 -TGA-
AATCCACCAAAGCTCACGC-3  (forward primer) and
5 -CCGAGGTCACCGCACAATCT-3  (reverse primer);
NeuroD1(494bp), 5 -GAGGAACACGAGGCAGACAAG-3 
(forward primer) and 5 -AAGAAAGTCCGAGGGTTGAGC-
3  (reverse primer); MafA (402bp), 5 -CCATCATCA-
CTCTGCCCACCAT-3  (forward primer) and 5 -CCC-
GCCAACTTCTCGTATTTCT-3  (reverse primer); insulin1
(327bp), 5 -CTATAAAGCTGGTGGGCATCC-3  (forward
primer) and 5 -AACGCCAAGGTCTGAAGGTC-3  (reverse
primer); insulin2 (368bp), 5 -AGCCTATCTTCCAGGTTA-
TTGTTTC-3  (forward primer) and 5 -GGTGGGTCTAGT-
TGCAGTAGTTCTC-3  (reverse primer); β-actin (517bp),
5 -ATATCGCTGCGCTGGTCGTC-3  (forward primer)
and5 -AGGATGGCGTGAGGGAGAGC-3  (reverseprimer).
Ampliﬁcation conditions included initial denaturation at
94◦C for 10min, followed by 35 cycles of denaturation at
94◦C for 30sec, annealing at 61◦C for 30sec and extension
at 72◦C for 30sec, at last an extension step of 10 min at 72◦C.
2.6. Immunoﬂuorescence Analysis. After being cultured for
21 days, infected cells were seeded on glass slides in a 12-well
culture plates and ﬁxed in 4% paraformaldehyde in PBS.
Permeabilizing and blocking was performed in 10% fetal calf
serum, 3% bovine serum albumin, and 0.2% triton X-100 in
PBS. Then the cells were incubated with primary antibody
(rabbit anti-mouse insulin polyclonal antibody 1:50; Santa
Cruz Biotechnology, CA, USA.) overnight at 4◦C. For insulin
staining, the cells were further incubated for 2h at room
temperature in the dark, with secondary antibody (Cy3
anti-rabbit 1:50; Proteintech Group, Chicago, IL USA).
After Hoechst staining for additional 15min, the slides
were washed and examined under the microscope. Images
were captured using an Olympus phase contrast ﬂuorescent
microscope (Olympus Corporation, Tokyo, Japan).
2.7. Insulin Secretion Assay. The infected cells or noninfected
cells were preincubated with Krebs-Ringer buﬀer (KRB) for
1h, followed by incubation for an additional 1h in KRB con-
taining10.0mMglucose.Thebuﬀerwascollectedandfrozen
at −80◦C until assay. Insulin enzyme-linked immunosorbent
assay (ELISA; Cusabio Biotech Co., Wuhan, Hubei, China)
was used for the quantitative determination of insulin levels
in the collected buﬀer according to the manufacturer’s pro-
tocol. All values were determined against a standard curve
prepared with mouse insulin.
2.8. Establishment of Diabetes Mellitus Models and Cell
Transplantation. To set up models of mice with diabetes,
adult C57BL/6J mice were injected intraperitoneally with
Streptozotocin (STZ; Sigma Chemical Company, St. Louis
Missouri, USA) at a dose of 160mg/kg. Hyperglycemia had
been made by the administration of this dose of STZ within
7 days. Blood glucose reached levels >16.7 mmol/L and kept
hyperglycemia for 2 weeks at least. Cells for transplantation
were prepared at the same time. Transcription factors
PDX-1, NeuroD1, and MafA were delivered into mMSCs
3 days before transplantation. Mice were anesthetized
with intraperitoneal injection of sodium pentobarbital at
50mg/kg, followed by the abdominal incision. About 1-
2 × 106 infected cells or non-infected cells suspended in
0.2ml PBS were transplanted into the liver parenchyma of
mice with diabetes. For the glucose tolerance test, mice were
injected intraperitoneally with 2.0g of glucose per kg body
weight after overnight fast. Blood glucose levels were mon-
itored at the indicated time points (0–120min) in samples
obtained from the tail vein of mice by using One-Touch
II portable blood glucose monitor (Lifescan Inc., Milpi-
tas, CA, USA). The mice were sacriﬁced two weeks after
transplantation. To witness the survival of the IPCs and
detect the insulin secretion of triple infected cells in the liver
tissues, the livers were removed and ﬁxed in 10% formalin.
Forty-eight hours later they were cut into serially sections4 Experimental Diabetes Research
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Figure 1: mMSC were induced into osteoblasts and adipocytes in vitro under diﬀerent diﬀerentiation medium. After incubation for 21 days,
the diﬀerentiated cells were stained with alkaline phosphatase (a) or oil red (b) for their multipotent characteristic.
and analyzed by immunohistochemistry. Negative controls
were also set up. mMSCs infected with Ad-GFP or mMSCs
without any infection were transplanted into the livers as
a control. Terminal deoxynucleotidyl transferase-mediated
biotinylated-dUTP nick-end labeling (TUNEL) assay was
also performed using the In Situ Cell Death Detection Kit,
Fluorescence(RocheApplied Science,Mannheim, Germany)
to determine whether the injected cells were apoptotic. The
livers were taken out immediately for making frozen tissue
sections. Frozen tissue sections were rinsed with PBS and
treated with 1% Triton X-100 in PBS for 2min on ice. Slides
were rinsed in PBS and incubated for 60 min at 37◦Cw i t h
50μL of TUNEL reaction mixture. After washing with PBS,
the slides were analyzed with ﬂuorescence microscopy.
3. Results
3.1. Production of Adenovirus Harboring PDX-1, NeuroD1 or
MafA. The sequences of the resultant recombinant aden-
oviruses, which encode PDX-1, NeuroD1, MafA, and GFP,
were conﬁrmed by gene sequencing and restriction endonu-
cleasedigestionswithPacI.Pac-I-digestedadenoviralvectors
were transfected into the 293A cell line to produce a crude
adenoviral stock and the adenovirus was ampliﬁed by infec-
ting 293 A cells. Various kinds of cells can be infected with
this adenovirus.
3.2. Derivation and Characterization of mMSCs In Vitro.
The unattached cells from the bone marrow samples
were removed through medium changes, and the adherent
mMSCs were cultured for propagation. After subsequent
passaging, most of the adherent cells exhibited fairly uni-
formly appearance. Immunophenotypes of the cells at pas-
sage 3 were assayed by ﬂow cytometry analysis. The majority
ofthecellsexpressed highlevelsofCD29, CD44, andCD105.
Meanwhile, the markers CD14, CD34, and CD45 displayed
extremely low expression. mMSCs were incubated in osteo-
genic and adipogenic diﬀerentiation medium to identify the
multipotency character, and it showed osteogenic diﬀerenti-
ation and adipogenic diﬀerentiation after 21 days (Figure 1).
These results indicated that the cultured cells were in the
undiﬀerentiated state and distinguished from haemopoietic
stem cells.
3.3.OptimizingtheMOIofmMSCs. Thesusceptibilityofdif-
ferent types of cells to adenovirus is variable and diﬀers sig-
niﬁcantly among the cell types. To achieve the optimal infec-
tion with adenovirus, we chose the optimal MOI to raise the
infectioneﬃciencyandalsotohavetheleastamountofcyto-
toxicity to the mMSCs simultaneously. The results indicated
that the infection eﬃciency improved constantly with the
increasingMOI.Whencellswereinfectedwithfreshlyadeno-
virus at MOI of 100, the infection eﬃciency was over 80%.
When cells were infected with fresh adenovirus at an MOI of
more than 2,400, the infection rate was almost 100%. On the
other hand, the cell survival became signiﬁcantly inhibited
with increasing MOI values beyond 600. The survival curves
showed that the number of living infected cells decreased
markedly when the MOI value was greater than 600
(Figure 2). From what had been shown above, we conclude
that infection of cells at an MOI of 600 is the optimal choice.
The cells were infected with viruses containing the three
factors at an MOI of 600. mMSCs were infected with diverse
single recombinant adenovirus, respectively, at an MOI of
200. mMSCs were infected with viruses containing any two
of these factors at an MOI of 400. The infected cells became
round in morphology and gave oﬀ strikingly bright green
ﬂuorescence 3 days after infection.
3.4.CombinationofPDX-1,NeuroD1,andMafAInducesIPCs
from mMSCs Signiﬁcantly In Vitro. To determine whether
the endogenous insulin gene started transcription, gene
expression proﬁles of exogenous transcription factors and
insulin gene were evaluated by RT-PCR. As illustrated in
Figure 3, the insulin gene and the transcription factor genes
were expressed in mMSCs, which were infected with the
corresponding transcription factors. The eﬀect of combina-
tion of the three factors was more profound compared with
any other groups. Consequently, the amount of insulin1 and
insulin2 mRNA expression in mMSCs with triple infectionExperimental Diabetes Research 5
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multiplicity of infection was determined by CCK-8. 10μL CCK-8
solution was added into the same amount of mMSCs which were
infected with Ad-GFP at diﬀerent MOI. Optical density of each well
varied directly with the survival of the cells. This experiment was
repeated six times. Values are mean ± SD.
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Figure 3: Adenovirus-mediated expression of PDX-1, NeuroD1,
and MafA together induced expression of the insulin gene in
infected mMSCs. mMSCs were infected with diverse single recom-
binant adenoviruses, both of the two adenoviruses, a combination
of the three adenoviruses, or Ad-GFP. Total RNA from mMSCs was
isolated 3d after infection, and RT-PCR analysis was performed
to examine expression of the speciﬁed genes. Cultured mMSCs
without infection served as the negative control.
was also much larger than any other groups (Figure 4). In
contrast, mMSCs infected with Ad-GFP or null, treated with
the same culture condition expressed no detectable level of
insulin gene or transcription factor gene. It is worthwhile
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Figure 4: Quantitation of the amount of insulin1 and insulin2 that
were produced by the infected mMSCs. The amount of insulin1 (a)
and insulin2 (b) mRNA expression in mMSCs with triple infection
was signiﬁcantly larger compared with any other group.
to note that transcription of PDX-1 and NeuroD1 could be
mutual activating, and exogenous MafA could trigger the
expression of the endogenous PDX-1 in mMSCs.
After infection, to determine the biosynthesis of insulin
and assay the insulin expression at the protein level, the
diﬀerentiated mMSCs were documented by immunoﬂuores-
cence analyses. All the cells on the slides were incubated with6 Experimental Diabetes Research
(a)
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(c)
Figure 5: Expression of insulin protein in the infected cells. After
culturing them for 21 days, all the infected cells were incubated
with anti-mouse insulin antibody. Nuclei were stained blue with
Hoechst dye (a). Most of the transgenic cells were stained positively
for insulin (b). In contrast, the mMSCs infected with Ad-GFP or
null were negative for insulin.
anti-mouse insulin and then red ﬂuorescence was clearly
visualized in the nucleus and cytoplasm after the triple
infection (Figure 5). Nuclei were stained blue with hoechst
dye. Red positive reactions were also observed after single
factor infection or both of the two factors infection. In con-
trast, the cultured cells infected with Ad-GFP or null were
negative for insulin.
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Figure 6: Insulin secretion of the infected cells which were
transferred into PDX-1, NeuroD1, MafA, or GFP at diﬀerent diﬀer-
entiationstagesinvitro.ThecellswereincubatedinKRBcontaining
the indicated concentration of glucose. The buﬀer was then collect-
ed for assay of insulin release in each experimental group. One
asterisk, ∗P<0.05. Data are presented as mean ± SD.
To further determine whether the function of insulin
secretion of the diﬀerentiated mMSCs, the amount of insulin
released by the cells in vitro at indicated concentrations of
glucose was measured using a mouse insulin ELISA kit. As
illustrated in Figure 6, the results showed that the insulin
content of the diﬀerentiated mMSCs which were infected
with combination of the three transcription factors was
signiﬁcantly higher than that of any other groups (P<0.05).
In addition, no insulin release was detected in the buﬀer
added to the cells infected with Ad-GFP or null.
3.5. Function Identiﬁcation of Induced Insulin-Producing
Cells In Vivo. Take a step further to determine whether
the induced IPCs give full scope to normal physiological
functions of β islet cells, mMSCs expressing a combination
of PDX-1, NeuroD1, and MafA were transplanted into the
livers of mice with STZ-induced diabetes. mMSCs infected
withAd-GFPorwithoutanyinfectionweretransplantedinto
the livers as a control. First, we examined insulin protein
expression and cell apoptosis in the tissue of liver. Insulin
content was not detected in the liver of mice treated with
mMSCs without infection but was indeed clearly detected
aftertreatmentwithmMSCsexpressedcombinationofPDX-
1, NeuroD1, and MafA (Figure 7). The immunoﬂuorescent
stainings of TUNEL were negative in the injected cells
(Figure 8), which indicated that they had never experienced
double-strand DNA breaks associated with apoptosis. In
addition, insulin protein expression was substantially dimin-
ished after 1 month and was not detectable after 2 months.
Furthermore, to assess the contribution on controlling bloodExperimental Diabetes Research 7
(a) (b)
(c) (d)
Figure 7: Immunohistochemistry assay for insulin of the survival infected mMSCs in the liver tissues of mice with diabetes. (a) Positive
control, anti-mouse insulin staining of mouse pancreatic specimen showing an intense expression of insulin (enlargement ×100). (b) Anti-
mouse insulin staining of pancreatic specimen of mice with STZ-induced diabetes showing a markedly decreased expression of insulin
(enlargement ×100). (c) Infected mMSCs were injected into the livers of mice with diabetes three days after infection. The positive staining
of mouse insulin expression can be clearly observed in the liver. (d) An enlargement of induced IPCs in the liver.
(a) (b)
Figure 8: TUNEL assay was performed to see whether the injected cells were apoptotic. (a) Frozen tissue sections of the livers were stained
with hoechst. (b) The immunoﬂuorescent stainings of TUNEL were negative in the transplanted cells.8 Experimental Diabetes Research
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Figure 9: Glucose responses to glucose tolerance test of mice with diabetes after transplantation. The infected cells which expressed
combination of PDX-1, NeuroD1, and MafA were transplanted into the livers of mice with STZ-induced diabetes, glucose tolerance test was
performed at 7 (a) and 14 days (b) following transplantation, compared with a normal control and diabetes models without any treatment.
Data are presented as mean ± SD.
glucose levels of insulin produced by the engrafted cells,
a glucose tolerance test was performed 7–14 days after
transplantation. As shown in Figure 9, the result revealed
that mMSCs expressing a combination of PDX-1, NeuroD1,
a n dM a f Aw e r ea b l et or e s p o n dt ot h eg l u c o s ec h a l l e n g e ,a n d
their response was almost comparable to that of normal β-
islet cells 7 days after transplantation. Notably, the same or
better eﬀect was not elicited after another 7 days. This is pro-
bably due to the fact that unstable and transient transgene
expression in the cells, plus induced cells failed to materialize
self-reproduction.Therewerenodiﬀerencesinbloodglucose
levels at any time point between mice with STZ-induced
diabetes implanted with normal mMSCs and nontransplan-
tation.
4. Discussion
In recent years, cell transplantation has become a research
hotspot concerning surgical methods for the treatment of
d i a b e t e s .I no r d e rt oo b t a i ns u r r o g a t eβ-cells, the target cells
weretransdiﬀerentiated, dediﬀerentiated, or diﬀerentiated to
surrogate β-cells in the usual by expressing some key tran-
scription factors involved in the pancreas development and
β-cell gene expression [18, 19]. In this study we report a pro-
cedure for delivery of combination of PDX-1, NeuroD1, and
MafA into mMSCs on adenoviral vectors and their diﬀeren-
tiation into IPCs in vitro or in vivo. Our results demonstrate
that bone marrow mesenchymal stem cells were induced for
directional diﬀerentiation into IPCs by a combination of just
three key transcription factors. Overexpression of PDX-1,
NeuroD1, and MafA markedly upregulated the expression of
insulin gene and also induced insulin biosynthesis and secre-
tion in mMSCs. The triple infection has a much stronger
inﬂuence compared with any single or double infection.
The β islet cells are unique in their ability to produce,
process, and secrete signiﬁcant amounts of insulin in a
strictly regulated manner in response to continuously vary-
ing concentrations of glucose [20]. The development process
and function maintenance of β-cells demand networking
regulation consisting of several transcription factors.
Previous research has suggested that stable expression of
PDX-1 in adult human mesodermal tissues activated expres-
sion of all four islet hormones including insulin and reversed
hyperglycemia in vivo, but more factors that stimulate cells
further toward diﬀerentiated normal β-cells were needed
[10]. In our study, any single factor and combinations of
any two factors were able to induce expression of insulin,
but the eﬀect elicited in mMSCs was too weak relative to the
particular combination of these three factors. It is apparently
not suﬃcient to drive diﬀerentiation of mMSCs a long way
toward β-cells or IPCs in the treatment of diabetes. A certain
fact to be reckoned with is that all the three transcription
factors are bound to the A3, E1, and C1 sites in a 340bp
promoter region upstream of the transcription start site of
the insulin gene [21–25]. In contrast or for further research,
we developed our experiments in vivo so that induced IPCs
would reside in their native environment and might be pro-
moted in their survival and maturation. As the homologous
featurebetween the liver and the pancreas has been displayed
in many animal samples [26], transplantation experimentsExperimental Diabetes Research 9
and in vitro diﬀerentiation experiments [27], in addition
that the liver is the primary organ where insulin functions,
we think the liver tissue is an ideal microenvironment for
IPCs to survive and function. Further work will be to explore
if additional factors are necessary for the particular com-
bination and mechanism among actions of the factors.
Intheexperimentsofgenedetection,genetictransforma-
tion of PDX-1 activated the expression of endogeneous Neu-
roD1 and endogeneous PDX-1 could be activated by exo-
genous NeuroD1 or MafA. The experimental results indi-
cated that adjustment or interaction may really exist between
each transcription factor. However, PDX-1 and MafA,
together with endogeneous NeuroD1 were unable to exert as
strong an inﬂuence on the expression of the insulin gene as
delivery of a combination of the three transcription factors.
We assume that ﬁne synergism could not be achieved due to
the low expression level of induced factors.
Intracellular GFP of the mMSCs was subsequently ini-
tiated to expression at 3 days after gene delivery, close toge-
ther with the factors. However, one week, later, the intensity
of the ﬂuorescence decreased with the degradation of partial
mitochondrialDNA.Therefore,inducedeﬃciencywassigni-
ﬁcantly inhibited without a repetition of infection. Cell
transplantation in liver parenchyma was done to fur-
ther verify the function of induced IPCs in vivo. Both intra-
peritoneal injection and high carbohydrate feeding are the
methods recommended by researchers for glucose tolerance
test. Comparatively, intraperitoneal injection goes in a
more accurate way for mice and is also simple to per-
form. The results of an IPGTT demonstrated the ability of
these implanted cells to dispose of a glucose load, and the
glucose tolerance was close to normal mice. However, it
should be noted that impaired glucose tolerance was found
after another 7 days. It may be the case that the implanted
induced IPCs failed to proliferate. Strategies that make stable
expression of the factors in mMSCs may possibly help to
evaluate the long term eﬀect of the treatment.
Bonemarrowmesenchymalstemcellhasbeenknownfor
their multiplex diﬀerentiation potential and relative ease to
obtain. They were able to be modiﬁed to develop epigenetic
changes, which were controlled by a series of several distinct
related genes, and then diﬀerentiated into functional β-cells.
In conclusion, our ﬁndings demonstrated that genetic
manipulationproducinginfectionbyacombinationofPDX-
1 NeuroD1, and MafA and their subsequent expression sig-
niﬁcantly promoted insulin-producing function of mMSCs.
Although substantial work has been done, the eﬀective
approach related to generation of surrogate β-cells for the
treatment of diabetes is still not obtained. Nevertheless, we
will further identify the diﬀerentiation of mMSCs expressed
combination of the just three factors in vivo and their stable
long-term expression for maintaining strict blood glucose
levels.
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